Objective: Endovascular aneurysm repair (EVAR) has reduced perioperative mortality for patients undergoing abdominal aortic aneurysm (AAA) repair despite the increase in elective aneurysm repair for the elderly. However, Medicare will not cover screening for beneficiaries older than 75 years, and AAA treatment in this population depends on incidental detection. Thus, we risk stratified elderly patients undergoing elective AAA repair to identify a subset of elderly patients who would potentially benefit from an expanded screening policy.
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VESS26. Objective: Vascular graft infection is a devastating and potentially deadly complication with often limited options for revascularization. Physician-prepared polymethyl methacrylate (PMMA) beads have been used to treat infections after orthopedic and soft tissue infections. This technique has been expanded for use in vascular graft salvage. We report our bead preparation and exchange protocol used for vascular graft infections during a 5-year period at our institution.
An Alternative Treatment of Vascular Graft
Methods: Between 2013 and 2018, there were 29 patients with vascular graft infections identified. Patients with previous prosthetic patch angioplasty, dialysis access procedures, or lower extremity prosthetic bypass grafts with culture-confirmed evidence of infection were included. PMMA beads were combined with culture-specific antibiotics and prepared by the surgeon at time of implantation. Patients underwent two or three series of wound débridement, pulse lavage, and antibiotic bead placement.
Results: Of the 29 patients treated with antibiotic PMMA beads, we were able to achieve graft salvage in 22 patients (76%). There were 26 patients who had threatened limbs from infections in lower extremity bypass grafts or femoral patch angioplasty site infections. In this group, we achieved limb salvage in 22 patients (85%). Three of the 26 patients (11.5%) at risk for limb loss required a new bypass (two extra-anatomic bypasses and lower extremity vein bypass in situ). One dialysis graft was not salvaged and was replaced.
Conclusions: We report an 85% limb salvage rate and a 76% graft salvage rate in patients with infected vascular grafts during a 5-year period using physician-prepared antibiotic beads. This technique is an important tool for salvaging infected vascular grafts and is an alternative to extra-anatomic bypass, complex or compromised dialysis access options, or amputation. We recommend two or three exchanges of the antibiotic beads with culture-specific antibiotics as available. Objective: Statin therapy and dosing intensity at hospital discharge are associated with higher long-term survival after vascular procedures. Discontinuation of statins and dosing changes are common, but the effect of these changes has yet to be characterized. We evaluated the association between statin intensity and long-term survival 1 year after lower extremity revascularization for chronic limb-threatening ischemia (CLTI).
Methods: We reviewed consecutive patients undergoing first-time endovascular or open revascularization for CLTI at a single institution from 2005 to 2014. We classified statin intensity by the American College of Cardiology/American Heart Association guidelines and evaluated change in statin intensity from discharge to 1-year follow-up. We compared long-term mortality beyond 1 year using Cox regression.
Results: We identified 1336 first-time revascularizations in 1195 patients with CLTI, of which 884 revascularizations in 792 patients had follow-up through 1 year. At 1 year, 165 patients (19%) were not taking a statin, 71 (8.3%) were receiving low-intensity therapy, 403 (47%) were receiving moderate-intensity therapy, and 221 (28%) were receiving high-intensity therapy. From discharge to 1-year follow-up, 101 patients (12%) had never taken a statin, 106 (12%) had their statin stopped or intensity decreased, 134 (16%) had a statin started or intensity increased, and 512 (60%) remained on stable statin therapy. In multivariable analysis, high-and moderate-intensity statin therapy at 1 year was associated with lower mortality compared with no statin therapy (high: hazard ratio Conclusions: High-or moderate-intensity statin therapy at 1 year after revascularization for CLTI is associated with higher long-term survival. However, a significant proportion of these patients had their statin stopped or intensity of therapy decreased within the first postoperative year, resulting in a loss of this survival difference. These results demonstrate the importance not only of discharging this population on highor moderate-intensity statin therapy but also of maintaining this therapy postoperatively.
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Comparison of Open and Endovascular Infrainguinal Procedures in Patients With Peripheral Artery Disease on Dialysis
Bala Ramanan, Haekyung Jeon-Slaughter, Shirling Tsai. University of Texas Southwestern Medical Center Dallas, Tex
Objective: Peripheral artery disease is a common comorbidity in patients with end-stage renal disease, but there is a paucity of data comparing outcomes of endovascular and open revascularization in this group of patients. In this study, we examined perioperative outcomes of lower extremity endovascular (LEE) revascularization and open lower extremity bypass (LEB) in patients on dialysis.
Methods: Patients on dialysis and undergoing LEE revascularization and LEB from 2011 to 2015 were identified in the American College of Surgeons National Surgical Quality Improvement Program targeted vascular data set. Patients' demographics, comorbidities, anatomic features, and perioperative outcomes were compared between LEE and LEB procedures.
Results: From 2011 to 2015, there were 1157 lower extremity revascularizations performed in dialysis patients. In this group, 608 were LEE (53%) and 549 were LEB (47%) procedures. Demographics such as age, sex, race, and body mass index were similar between the two groups (P > .05). Patients undergoing open and endovascular procedures had similar rate of comorbidities of hypertension, smoking, congestive heart failure, diabetes, chronic obstructive pulmonary disease, and bleeding disorders. Only 50 (4%) procedures were done emergently, and there was a similar rate in the two groups. A majority of the procedures (n ¼ 1033 [89.7%]) were done for critical limb ischemia. Preoperative aspirin and beta blocker use was higher in the LEE group, and statin use was similar between the two groups. Table I compares postoperative outcomes on univariate analysis between the two groups. On risk-adjusted multivariate analysis (Table II) , LEB was associated with a lower rate of major amputation but a higher rate of postoperative bleeding and wound complications. Thirty-day mortality and cardiovascular morbidity were similar between the two groups.
Conclusions: In dialysis patients, LEB is associated with a lower risk of major limb amputation but a higher rate of postoperative wound complications and bleeding compared with LEE revascularization. Cardiovascular complications, 30-day mortality, and reinterventions were similar in the two groups. In dialysis patients who are a good surgical risk and with an appropriate target, lower extremity bypass procedures should be strongly considered for infrainguinal revascularization to achieve better limb salvage. Longer term outcomes comparing the two types of procedures are needed. 
